Stockscreener 앱 받기
113.87
1.36%
-1.57
전일 마감가:
$115.44
열려 있는:
$114.64
하루 거래량:
29.49M
Relative Volume:
2.90
시가총액:
$281.24B
수익:
$65.51B
순이익/손실:
$8.93B
주가수익비율:
32.05
EPS:
3.5532
순현금흐름:
$14.12B
1주 성능:
-5.71%
1개월 성능:
+1.16%
6개월 성능:
+13.09%
1년 성능:
+43.61%
1일 변동 폭
$111.57
$114.94
1주일 범위
$111.57
$121.90
52주 변동 폭
$76.66
$125.14
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
113.87 | 281.24B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,098.57 | 979.64B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
228.39 | 549.78B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
216.49 | 382.49B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
147.08 | 280.64B | 54.66B | 13.58B | 16.05B | 7.0171 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-02-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck & Co. Stockweekly review and pharma peer comparison - AD HOC NEWS
Penn Series Large Core Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
LVIP MFS Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co., Inc. Sued for Securities Law ViolationsInvestors - The National Law Review
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook - The Motley Fool
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens - Benzinga
Merck wins U.S. label expansion for pneumococcal shot (MRK:NYSE) - Seeking Alpha
Merck's pneumococcal vaccine wins US approval for high-risk children, teens - Reuters
Here’s Why Merck (MRK) is Among the 10 Undervalued Counter Cyclical Stocks to Buy Now - Insider Monkey
WRIGHT INVESTORS SERVICE INC's Merck & Co Inc(MRK) Holding History - GuruFocus
JPMorgan Growth Advantage Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
A Look at Merck & Co Inc (MRK) After 3.5% Decline -- GF Value $1 - GuruFocus
Merck & Co. Inc. stock underperforms Monday when compared to competitors - MarketWatch
Merck & Co Inc Stock (MRK) Moved Down by 3.13% on Jun 15: What Signal Does It Send? - TradingKey
Panagora Asset Management Inc. Purchases 567,249 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Resources Management Corp CT ADV - MarketBeat
Vanguard Personalized Indexing Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
MFS Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Perryman Financial Advisory Inc. AD Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Mariner LLC Has $289.84 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Kennedy Capital Management LLC Sells 16,448 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Evelyn Partners Investment Management LLP - MarketBeat
Merck & Co. Inc. Stock (US58933Y1055): Valuation and fundamentals in focus after steady trading - AD HOC NEWS
Gross margin % of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Focus Partners Wealth Has $149.61 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Total common shares outstanding of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Enterprise value to EBITDA ratio of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Current ratio of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Huber Capital Management LLC Buys 10,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
LM Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Epoch Investment Partners Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Arax Advisory Partners Has $30.94 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Brown Advisory Inc. Purchases 36,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bollard Group LLC Has $13.90 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
INVESCO V.I. Health Care Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. Inc. Stock (US58933Y1055): Insider and institutional ownership in focus - AD HOC NEWS
Van Lanschot Kempen Investment Management N.V. Sells 82,120 Shares of Merck & Co., Inc. $MRK - MarketBeat
Storgate LLC Acquires Shares of 9,673 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Korea Investment CORP - MarketBeat
Martingale Asset Management L P Has $34.08 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Platinum Investment Management Ltd. Sells 875,470 Shares of Merck & Co., Inc. $MRK - MarketBeat
Trillium Asset Management LLC Has $10.25 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Macquarie Group Ltd. Has $186.10 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
First National Bank of Omaha Purchases 85,885 Shares of Merck & Co., Inc. $MRK - MarketBeat
Summit Financial LLC Purchases 17,528 Shares of Merck & Co., Inc. $MRK - MarketBeat
9,619,320 Shares in Merck & Co., Inc. $MRK Bought by Cardano Risk Management B.V. - MarketBeat
Merck & Co., Inc. $MRK Stake Decreased by Cullen Capital Management LLC - MarketBeat
Number of shareholders of Merck & Co., Inc. – MIL:1MRKX - TradingView
33,787 Shares in Merck & Co., Inc. $MRK Purchased by Gator Capital Management LLC - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
자본화:
|
볼륨(24시간):